Last quarter (Q ), Endonovo Therapeutics's total revenue was $1.52K, a decrease of -86.13% from the same quarter last year. In Q, Endonovo Therapeutics's net income was $-766.17K. See Endonovo Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ -13.77M	$ 135.35K	$ 73.11K	$ 165.80K	$ 310.16K	$ 83.26K
Cost of Revenue	$ 11.95K	$ 9.99K	$ 14.98K	$ 65.37K	$ 93.39K	$ 12.93K
Gross Profit	$ -13.78M	$ 125.36K	$ 58.12K	$ 100.43K	$ 216.78K	$ 70.33K
Operating Expense	$ 7.22M	$ 3.39M	$ 2.28M	$ 3.01M	$ 4.03M	$ 4.23M
Operating Income	$ -15.41M	$ -3.26M	$ -2.23M	$ -2.91M	$ -3.81M	$ -4.16M
Net Non Operating Interest Income Expense	$ 938.82K	$ -1.32M	$ -941.57K	$ -2.08M	$ -6.09M	$ -5.20M
Other Income Expense	$ -3.53M	$ 13.89M	$ -22.16K	$ 4.60M	$ -7.42M	$ 2.92M
Pretax Income	$ -4.40M	$ -18.47M	$ -3.15M	$ -395.58K	$ -17.31M	$ -6.44M
Tax Provision	-	-	-	$ 0.00	$ 0.00	$ 0.00
Earnings From Equity Interest Net Of Tax	-	$ -14.03M	-	-	-	-
Net Income Common Stockholders	$ -11.20M	$ -18.47M	$ -3.15M	$ -395.58K	$ -17.31M	$ -6.44M
Basic EPS	$ -0.05	$ -0.13	$ -0.05	$ -0.03	$ -24.83	$ -17.76
Diluted EPS	$ -7.73M	$ -0.13	$ -0.05	$ -0.03	$ -24.83	$ -17.76
Basic Average Shares	$ 965.28M	$ 139.21M	$ 59.84M	$ 12.22M	$ 697.30K	$ 362.47K
Diluted Average Shares	$ 4.44B	$ 139.21M	$ 59.84M	$ 12.22M	$ 697.30K	$ 362.47K
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 7.23M	$ 3.40M	$ 2.30M	$ 3.08M	$ 4.12M	$ 4.24M
Net Income From Continuing And Discontinued Operation	$ -4.40M	$ -18.47M	$ -3.15M	$ -395.58K	$ -17.31M	$ -6.44M
Normalized Income	$ 1.03M	-	-	$ -5.45M	$ -9.90M	$ -9.36M
Interest Expense	-	-	-	$ 2.08M	$ 6.09M	$ 5.20M
EBIT	$ -5.03M	$ -17.15M	$ -2.20M	$ 1.69M	$ -11.22M	$ -1.24M
EBITDA	$ -4.37M	$ -16.40M	$ 0.00	$ 2.34M	$ -10.57M	$ -588.50K

Currency in USD

Endonovo Therapeutics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing